Medicare Enrolled
Dr. Matthew Petitt, DO
Dermatopathology Physician · Pasadena, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Petitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petitt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Petitt
Dr. Matthew Petitt is a dermatopathology physician in Pasadena, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Petitt performed 9,549 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Petitt received a total of $20,308 from 52 pharmaceutical and/or device companies across 1024 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Petitt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 16% volume in TX
$20,308 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,549
Medicare services
Top 16% in TX for dermatopathology physician
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
4,447 | $57 | $170 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,402 | $5 | $25 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
652 | $23 | $47 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
463 | $67 | $152 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
437 | $35 | $111 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
380 | $69 | $175 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
253 | $34 | $96 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $92 | $215 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
229 | $40 | $89 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
221 | $28 | $58 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
132 | $85 | $191 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
122 | $92 | $186 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
82 | $78 | $186 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
47 | $340 | $731 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
47 | $68 | $134 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
40 | $127 | $278 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
34 | $108 | $300 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
33 | $1 | $5 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
32 | $102 | $416 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $119 | $279 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
30 | $388 | $806 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
26 | $304 | $684 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 26 | $110 | $317 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
25 | $83 | $219 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
25 | $112 | $455 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
22 | $56 | $167 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
19 | $117 | $473 |
| Destruction of skin growth, 15 or more growths | 14 | $95 | $224 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $47 | $93 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
12 | $144 | $346 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
11 | $105 | $429 |
| All potassium hydroxide (koh) preparations | 11 | $6 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$20,308
Total received (2018-2024)
Avg $2,901/year across 7 years
Top 14% in TX for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,024
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,297
2023
$4,331
2022
$3,187
2021
$2,408
2020
$2,091
2019
$2,127
2018
$1,866
Payments by company (2024)
ABBVIE INC.
$705
Janssen Biotech, Inc.
$670
GENZYME CORPORATION
$363
PFIZER INC.
$323
Novartis Pharmaceuticals Corporation
$303
Lilly USA, LLC
$247
Dermavant Sciences, Inc.
$246
Amgen Inc.
$234
Incyte Corporation
$233
Arcutis Biotherapeutics, Inc.
$207
Regeneron Healthcare Solutions, Inc.
$201
LEO Pharma Inc.
$82
Ortho Dermatologics, a division of Bausch Health US, LLC
$76
Mallinckrodt Hospital Products Inc.
$73
SUN PHARMACEUTICAL INDUSTRIES INC.
$64
Paratek Pharmaceuticals, Inc.
$52
UCB, Inc.
$46
Tempus AI, Inc
$37
E.R. Squibb & Sons, L.L.C.
$36
Almirall LLC
$35
Organogenesis Inc.
$22
Teva Pharmaceuticals USA, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,108
Novartis Pharmaceuticals Corporation
$1,967
ABBVIE INC.
$1,888
Regeneron Healthcare Solutions, Inc.
$1,288
Lilly USA, LLC
$1,268
GENZYME CORPORATION
$1,080
LEO Pharma Inc.
$1,071
PFIZER INC.
$969
Sun Pharmaceutical Industries Inc.
$829
Amgen Inc.
$827
AbbVie, Inc.
$633
Arcutis Biotherapeutics, Inc.
$546
Incyte Corporation
$502
AbbVie Inc.
$499
Dermavant Sciences, Inc.
$447
UCB, Inc.
$400
Ortho Dermatologics, a division of Bausch Health US, LLC
$380
Galderma Laboratories, L.P.
$373
Organogenesis Inc.
$365
Celgene Corporation
$348
Paratek Pharmaceuticals, Inc.
$302
Almirall LLC
$273
MAYNE PHARMA INC.
$238
Genentech USA, Inc.
$218
Hill Dermaceuticals, Inc.
$213
SUN PHARMACEUTICAL INDUSTRIES INC.
$161
Mayne Pharma Inc.
$140
Encore Dermatology Inc.
$116
DERMIRA, INC.
$114
EPI Health, LLC
$85
Mallinckrodt Hospital Products Inc.
$73
Journey Medical Corporation
$71
Medimetriks Pharmaceuticals, Inc.
$64
VYNE Pharmaceuticals Inc.
$51
Biofrontera Inc.
$44
Tempus AI, Inc
$37
E.R. Squibb & Sons, L.L.C.
$36
DUSA Pharmaceuticals, Inc.
$32
Nabriva Therapeutics, plc
$27
Mylan Pharmaceuticals Inc.
$25
Sebela Pharmaceuticals Inc.
$24
Merck Sharp & Dohme Corporation
$22
ORGANOGENESIS INC.
$20
Teva Pharmaceuticals USA, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
Melinta Therapeutics, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
SANOFI-AVENTIS U.S. LLC
$11
Promius Pharma LLC
$11
Aclaris Therapeutics, Inc.
$11
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ACTHAR · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BRYHALI · Baxdela · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · Cordran · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DermOtic · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · EVUSHELD · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Merlin Test · NUZYRA · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PRAMOSONE · Puraply · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIMLANDI · SIVEXTRO · SKYRIZI · SOOLANTRA · SORILUX · SPEVIGO · Sernivo Spray · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Tremfya · VALCHLOR · VTAMA · Veltin · Winlevi · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatopathology physicians in nearby ZIP areas
14
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE SOUTHEAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Petitt is a mixed practice specialist, with above-average Medicare volume (top 16% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Petitt experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Petitt performed 4,447 tissue pathology examination, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Petitt receive payments from pharmaceutical companies?
Yes. Dr. Petitt received a total of $20,308 from 52 companies across 1,024 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Petitt's costs compare to other dermatopathology physicians in Pasadena?
Dr. Petitt's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Petitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Pasadena
Browse dermatopathology physicians in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in TX
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in TX
Which TX dermatopathology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology